Shire PLC has named Thomas Dittrich CFO and a member of the rare disease specialist's executive committee. Dittrich will assume his roles at Shire in early 2018 after a transition period from his current employer, global industrial engineering and manufacturing company Sulzer Ltd, where he is CFO. Dittrich joined Sulzer in August 2014, serving as interim CEO between August and December 2015. There, he helped design Sulzer's transformation program, driving key upgrades to finance and IT functions, as well as to its capital structure and resource allocation initiatives.
Biogen Inc. appointed Jeffrey D. Capello CFO effective Dec. 11 where he will lead the group’s business planning, tax, treasury, internal audit, accounting, and investor relations functions and report to Biogen CEO Michel Vounatsos. Capello brings 26 years of experience in finance and will be based in Cambridge, Massachusetts. Most recently, he was executive vice president and CFO at Beacon Health Options Inc
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Scrip for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?